LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received 510(k) clearance for extracorporeal membrane oxygenation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback